BERTI, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 16.947
AS - Asia 8.054
EU - Europa 6.001
SA - Sud America 1.351
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 166
OC - Oceania 11
Totale 32.725
Nazione #
US - Stati Uniti d'America 16.052
SG - Singapore 2.773
CN - Cina 1.775
HK - Hong Kong 1.406
IT - Italia 1.193
RU - Federazione Russa 1.041
BR - Brasile 1.012
VN - Vietnam 890
UA - Ucraina 848
CA - Canada 764
SE - Svezia 671
IE - Irlanda 655
DE - Germania 454
GB - Regno Unito 303
FR - Francia 280
BD - Bangladesh 222
FI - Finlandia 202
IN - India 164
KR - Corea 151
NL - Olanda 136
AR - Argentina 118
IQ - Iraq 98
TR - Turchia 84
ZA - Sudafrica 73
JP - Giappone 70
MX - Messico 57
ID - Indonesia 54
EC - Ecuador 51
PK - Pakistan 51
SA - Arabia Saudita 50
AT - Austria 47
PH - Filippine 43
CO - Colombia 41
VE - Venezuela 39
ES - Italia 37
UZ - Uzbekistan 37
PY - Paraguay 25
BE - Belgio 24
CL - Cile 24
MA - Marocco 24
DK - Danimarca 23
KE - Kenya 20
MY - Malesia 20
PL - Polonia 20
IR - Iran 18
PE - Perù 17
TN - Tunisia 17
JM - Giamaica 16
NP - Nepal 16
TH - Thailandia 16
CR - Costa Rica 15
EG - Egitto 15
ET - Etiopia 15
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
UY - Uruguay 12
BO - Bolivia 11
AZ - Azerbaigian 10
AL - Albania 9
AU - Australia 9
CH - Svizzera 9
DZ - Algeria 9
JO - Giordania 9
PS - Palestinian Territory 9
GR - Grecia 8
HN - Honduras 8
TT - Trinidad e Tobago 8
KZ - Kazakistan 7
PA - Panama 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
KG - Kirghizistan 6
NI - Nicaragua 6
OM - Oman 6
RO - Romania 6
EU - Europa 5
GE - Georgia 5
GT - Guatemala 5
HU - Ungheria 5
SN - Senegal 5
AM - Armenia 4
BH - Bahrain 4
LT - Lituania 4
LY - Libia 4
KH - Cambogia 3
KW - Kuwait 3
BB - Barbados 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
HR - Croazia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SV - El Salvador 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 32.541
Città #
Ann Arbor 1.860
Woodbridge 1.768
Singapore 1.481
Hong Kong 1.388
Ashburn 1.145
Houston 1.110
Fairfield 1.083
Jacksonville 930
San Jose 608
Dublin 607
Chandler 527
Toronto 477
Seattle 461
Wilmington 442
Santa Clara 432
New York 381
Cambridge 372
Princeton 350
Milan 338
Dearborn 312
Chicago 289
Beijing 282
The Dalles 240
Council Bluffs 238
Ho Chi Minh City 219
Hanoi 200
Hefei 187
Frankfurt am Main 174
Lachine 169
Lawrence 164
Nanjing 161
Altamura 156
Los Angeles 155
Lauterbourg 146
Seoul 141
Moscow 117
Dallas 102
Rome 97
São Paulo 94
Buffalo 86
San Diego 77
Dong Ket 74
Huizen 71
Andover 66
Guangzhou 66
Shanghai 63
Rio de Janeiro 54
Boardman 53
Munich 48
Shenyang 48
Nanchang 47
Hebei 40
Ottawa 39
Haiphong 37
Phoenix 37
Baghdad 36
Jiaxing 36
Da Nang 35
Vienna 34
Changsha 31
Detroit 31
London 31
Orem 30
Tashkent 30
Tianjin 30
Tokyo 30
Helsinki 28
Mountain View 27
Norwalk 27
Atlanta 26
Johannesburg 25
Naples 25
Amsterdam 24
Belo Horizonte 24
Salt Lake City 23
St Louis 23
Dhaka 22
Turin 22
Brooklyn 21
Columbus 21
Quito 21
Tampa 21
Brasília 19
Las Vegas 19
Elk Grove Village 18
Falls Church 18
University Park 18
Zhengzhou 18
Chennai 17
Jeddah 17
Nairobi 17
Philadelphia 17
Bologna 16
Boston 16
Lahore 16
Nuremberg 16
Campinas 15
Denver 15
Hải Dương 15
Figino 14
Totale 21.344
Nome #
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 378
Unusual variants of non-Langerhans cell histiocytosis 304
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas 299
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 275
Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment 272
Increased risk of venous thromboembolism in patients with bullous pemphigoid: The INVENTEP (INcidence of VENous Thromboembolism in bullous Pemphigoid) study 266
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 260
The CALOCUBE project for a space based cosmic ray experiment: Design, construction, and first performance of a high granularity calorimeter prototype 259
Elevated circulating CA 15.3 levels in a subset of systemic sclerosis with severe lung involvement 257
POF1B Localizes to Desmosomes and Regulates Cell Adhesion in Human Intestinal and Keratinocyte Cell Lines 254
Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma 254
CaloCube: A new-concept calorimeter for the detection of high-energy cosmic rays in space 254
Photopheresis in cutaneous T-cell lymphoma: five-year experience 246
Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases 246
Radiotherapy of cutaneous B cell lymphomas: Our experience in 31 cases 245
Aggressive epidermotropic cutaneous CD8+ lymphoma: A cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop 245
Granulomatous vasculitis 244
bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas 243
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response 242
Cutaneous lymphoid hyperplasia associated with Leishmania panamensis infection 236
La giunzione dermo-epidermica 236
Expression of cell cycle regulatory proteins and analysis of apoptosis in normal nasal mucosa and in nasal polyps 236
Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukaemia 234
Molecular analysis of cutaneous B- and T-cell lymphomas 233
Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma 231
To classify or to discern? That's the problem 230
Thalidomide treatment for hypertrophic cutaneous lupus erythematosus 229
Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas 227
Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients with Inflammatory Bowel Diseases 227
Sneddon's syndrome: clinical and immunohistochemical findings 227
Chronic bullous disease of childhood and ulcerative colitis 226
Activation of blood coagulation in two prototypic autoimmune skin diseases: A possible link with thrombotic risk 226
Onycolemmal carcinoma 225
New monoclonal antibodies against B-cell antigens: Possible new strategies for diagnosis of primary cutaneous B-cell lymphomas 225
Subcutaneous panniculitis-like T-cell lymphoma 225
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model 225
Detection of Polyomavirus in Merkel cell carcinoma by immunohistochemistry: report of three cases 223
Sézary Syndrome in a 17-Year-Old Boy: Clinicopathologic Features and Genomic Profile 222
Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm 219
Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study 217
Pustular skin reaction to tumor necrosis factor alpha antagonists in patients with inflammatory bowel diseases 216
Cytokine and chemokine profile in amicrobial pustulosis of the folds evidence for autoinflammation 216
Simultaneous onset of primary cutaneous B-cell lymphoma and human herpesvirus 8-associated Kaposi's sarcoma 215
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma 214
Ichthyosis Curth-Macklin: a new sporadic case with immunohistochemical study of keratin expression 212
Kaposi's sarcoma and herpes virus like DNA sequences in sensory ganglia 211
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas 211
WHO/EORTC classification of cutaneous lymphomas 2005: Histological and molecular aspects 209
Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castelmann disease 209
CD30/Ki-1-positive lymphoproliferative disorders of the skin - Clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the European organization for research and treatment of cancer cutaneous lymphoma project group 209
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sezary syndrome 208
Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entity 208
Primary cutaneous CD30‐positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients 207
Lichen striatus – a chameleon: An histopathological and immunohistological study of forty‐one cases 207
HHV8 cell associated viraemia and clinical presentation of mediterranean Kaposi's sarcoma 206
Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions 205
Human epidermal Langerhans cells express the ICAM-3 molecule. Immunohistochemical and immunoelectron microscopical demonstration 205
Eruption resembling erythema gyratum repens in linear IgA dermatosis 205
Skin involvement in cutaneous and systemic vasculitis 205
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 205
C/EBPd Gene Targets in Human Keratinocytes 204
Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses 204
Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen 204
Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation 203
CD30-positive multilobated peripheral T-cell lymphoma primarily involving the subcutaneous tissue 202
Oncogenesis in HIV-infection 202
Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa 201
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily 201
Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature 200
Angiocentric and intravascular lymphomas 200
Differenital virual protein expression in Kasposi's sarcoma associated herpesvirus-infected disease: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease 199
Unique digital skin lesions associated with systemic sclerosis 199
The perikaryal surface of spinal ganglion neurons: differences between domains in contact with satellite cells and in contact with the extracellular matrix 199
Unilesional follicular mycosis fungoides 196
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11) 196
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT 195
Peristomal bullous pemphigoid 195
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions 194
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture 194
Natural killer and t-cell cytotoxic cutaneous lymphomas 193
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: A distinct clinicopathological entity with an aggressive clinical behavior 191
Parapsoriasis in Two Children: A Clinical, Immunophenotypic, and Immunogenotypic Study 189
Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases 189
Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like t-lymphoma: report of 7 cases 188
Oral and cutaneous findings are valuable diagnostic aids in Wegener's granulomatosis 188
Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization 188
Primary cutaneous peripheral T-cell lymphomas, rare subtypes 186
Fibrogenic cytokines in vulvar lichen sclerosus: An immunohistochemical study 186
Human herpesvirus-8 in AIDS-related and unrelated lymphomas 186
Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas 185
Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium 184
Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia 184
Delta chain-positive T-cell lymphoma of the skin 184
Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies 183
Unusual hyperpigmentation developing in congenital reticular ichthyosiform erythroderma (ichthyosis variegata) 183
Prevalence of Chlamydial Infection in a Series of 108 Primary Cutaneous Lymphomas 182
Science with the space-based interferometer eLISA: Supermassive black hole binaries 182
Experimental vitreous replacement with perfluorophenanthrene 180
Mycosis fungoides: disease evolution of the "lion queen" revisited 179
Idiopathic capillary leak syndrome: evidence of CD8-positive lymphocytes surrounding damaged endothelial cells 178
Totale 21.681
Categoria #
all - tutte 115.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.122 0 0 132 108 65 66 53 75 153 82 123 265
2022/20232.462 416 607 173 156 240 455 15 104 204 9 50 33
2023/20241.634 60 50 46 22 272 482 334 24 207 19 9 109
2024/20254.520 282 794 257 194 394 65 282 137 368 651 248 848
2025/202610.308 825 843 864 1.114 929 591 1.220 732 888 842 798 662
2026/20271.116 393 514 209 0 0 0 0 0 0 0 0 0
Totale 32.725